Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1060 participants.

Also called NCT07141303

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,060 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07141303
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07141303. Randomized; quadruple masking; primary purpose treatment. Start 2025-08-08 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion
Acronym
IMPACT-LVO
Condition
Acute Ischemic Stroke
Intervention (Drug)
The methylprednisolone sodium succinate
Intervention (Drug)
Placebo
Lead sponsor
Tang-Du Hospital (class: other)
Collaborator
First People's Hospital of Xianyang (class: other)
Collaborator
First People's Hospital Of Tianshui (class: not stated)
Collaborator
XD Group Hospital (class: not stated)
Collaborator
Xi'an Aerospace General Hospital (class: other)
Collaborator
First Affiliated Hospital of Chengdu Medical College (class: other)

Record details

Record id
cardio:ct-nct07141303
Content hash
634a914c42b15293a69db76a91a5f5ddd7d3d348414c12c4314385af4503e14b